Marcy l’Etoile, le 23 septembre 2021

Cynbiose SAS, a preclinical CRO, and HawkCell, a young innovative company specialized in MRI (Magnetic Resonance Imaging) for small and large animals, join forces to offer a global R&D and commercial service for preclinical studies focused on the non-human primate model.

The partnership between Cynbiose and HawkCell will provide both a collaborative R&D offer with biopharmaceutical companies for the development and characterization of physiopathological models. It will also strengthen imaging capabilities for preclinical studies in the translational NHP model.

Lire le communiqué (en)

Press release – Cynbiose HawkCell partnership in MRI – Sept 2021
Télécharger